Bulgaria Resumed Administering the AstraZeneca COVID-19 Vaccine

SOFIA, Bulgaria — Bulgaria on Friday resumed administering the AstraZeneca COVID-19 vaccine after the European Union's drug regulator confirmed the vaccine was safe.

Bogdan Kirilov, executive director of the Bulgarian Drug Agency, cited an official statement from the European Medicines Agency confirming the effectiveness of the vaccine.

“The benefits of AstraZeneca’s vaccine outweigh any potential risks,” he said.

Bulgaria temporarily suspended the rollout of the AstraZeneca vaccine a week ago. Authorities hope the pause has not undermined public confidence in the country's overall vaccination drive, which already was not very high.

In the Balkan nation of 7 million, only some 355,000 people have been vaccinated with a first dose so far, which is the lowest number in the European Union.


ATHENS – While the New Democracy government is easing health restrictions for rabid anti-vaxxers, those fully vaccinated against COVID-19 may need a fourth shot in the autumn.

Top Stories

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

General News

PHILADELPHIA – The Federation of Hellenic Societies of Philadelphia and Greater Delaware Valley announced that the Evzones, the Presidential Guard of Greece will be participating in the Philadelphia Greek Independence Day Parade on March 20.


Mitsotakis Meets with Biden at the White House (Video)

WASHINGTON, DC – Greek Prime Minister Kyriakos Mitsotakis met with US President Joe Biden at the White House on Monday, in the first day of an official two-day visit to the American capital.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. abc@xyz.com

You may unsubscribe at any time using the link in our newsletter.